Annual EBITDA
-$163.14 M
-$92.67 M-131.50%
December 31, 2022
Summary
- As of February 26, 2025, SLGCW annual EBITDA is -$163.14 million, with the most recent change of -$92.67 million (-131.50%) on December 31, 2022.
- During the last 3 years, SLGCW annual EBITDA has fallen by -$131.84 million (-421.17%).
- SLGCW annual EBITDA is now -421.17% below its all-time high of -$31.30 million, reached on December 31, 2020.
Performance
SLGCW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$18.18 M
+$11.55 M+38.84%
September 30, 2023
Summary
- As of February 26, 2025, SLGCW quarterly EBITDA is -$18.18 million, with the most recent change of +$11.55 million (+38.84%) on September 30, 2023.
- Over the past year, SLGCW quarterly EBITDA has stayed the same.
- SLGCW quarterly EBITDA is now -3246.02% below its all-time high of $578.00 thousand, reached on December 31, 2020.
Performance
SLGCW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$135.63 M
+$18.84 M+12.20%
September 30, 2023
Summary
- As of February 26, 2025, SLGCW TTM EBITDA is -$135.63 million, with the most recent change of +$18.84 million (+12.20%) on September 30, 2023.
- Over the past year, SLGCW TTM EBITDA has stayed the same.
- SLGCW TTM EBITDA is now -2454.24% below its all-time high of -$5.31 million, reached on December 31, 2020.
Performance
SLGCW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLGCW EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -131.5% | 0.0% | 0.0% |
| 3 y3 years | -421.2% | 0.0% | 0.0% |
| 5 y5 years | -421.2% | 0.0% | 0.0% |
SLGCW EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -131.5% | at low | at high | +62.3% | -62.3% | +20.4% |
| 5 y | 5-year | -421.2% | at low | -3246.0% | +62.3% | -2454.2% | +20.4% |
| alltime | all time | -421.2% | at low | -3246.0% | +62.3% | -2454.2% | +20.4% |
SomaLogic EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$18.18 M(-38.8%) | -$135.63 M(-12.2%) |
| Jun 2023 | - | -$29.73 M(-24.7%) | -$154.47 M(-9.3%) |
| Mar 2023 | - | -$39.51 M(-18.0%) | -$170.32 M(+3.9%) |
| Dec 2022 | -$163.14 M | -$48.21 M(+30.2%) | -$163.90 M(+18.6%) |
| Sep 2022 | - | -$37.02 M(-18.8%) | -$138.24 M(-2.7%) |
| Jun 2022 | - | -$45.59 M(+37.8%) | -$142.10 M(+30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$33.08 M(+46.7%) | -$109.03 M(+30.5%) |
| Dec 2021 | -$70.47 M(+125.1%) | -$22.55 M(-44.9%) | -$83.56 M(+38.3%) |
| Sep 2021 | - | -$40.88 M(+226.7%) | -$60.43 M(+137.6%) |
| Jun 2021 | - | -$12.52 M(+64.5%) | -$25.43 M(+96.9%) |
| Mar 2021 | - | -$7.61 M(-1416.1%) | -$12.92 M(+143.3%) |
| Dec 2020 | -$31.30 M | $578.00 K(-109.8%) | -$5.31 M(-9.8%) |
| Sep 2020 | - | -$5.89 M | -$5.89 M |
FAQ
- What is SomaLogic annual EBITDA?
- What is the all time high annual EBITDA for SomaLogic?
- What is SomaLogic annual EBITDA year-on-year change?
- What is SomaLogic quarterly EBITDA?
- What is the all time high quarterly EBITDA for SomaLogic?
- What is SomaLogic quarterly EBITDA year-on-year change?
- What is SomaLogic TTM EBITDA?
- What is the all time high TTM EBITDA for SomaLogic?
- What is SomaLogic TTM EBITDA year-on-year change?
What is SomaLogic annual EBITDA?
The current annual EBITDA of SLGCW is -$163.14 M
What is the all time high annual EBITDA for SomaLogic?
SomaLogic all-time high annual EBITDA is -$31.30 M
What is SomaLogic annual EBITDA year-on-year change?
Over the past year, SLGCW annual EBITDA has changed by -$92.67 M (-131.50%)
What is SomaLogic quarterly EBITDA?
The current quarterly EBITDA of SLGCW is -$18.18 M
What is the all time high quarterly EBITDA for SomaLogic?
SomaLogic all-time high quarterly EBITDA is $578.00 K
What is SomaLogic quarterly EBITDA year-on-year change?
Over the past year, SLGCW quarterly EBITDA has changed by $0.00 (0.00%)
What is SomaLogic TTM EBITDA?
The current TTM EBITDA of SLGCW is -$135.63 M
What is the all time high TTM EBITDA for SomaLogic?
SomaLogic all-time high TTM EBITDA is -$5.31 M
What is SomaLogic TTM EBITDA year-on-year change?
Over the past year, SLGCW TTM EBITDA has changed by $0.00 (0.00%)